Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 91

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 91
---
 or licensed intellectual property. Accordingly,
we cannot predict the breadth of claims that may be enforced in the patents that may be issued from the applications we currently or
may in the future own or license from third parties. Further, if any patents we obtain or license are deemed invalid or unenforceable,
our ability to commercialize or license our technology could be adversely affected.

Others have filed, and in
the future are likely to file, patent applications covering products and technologies that are similar, identical or competitive to ours
or important to our business. We cannot be certain that any patent application owned by a third party will not have priority over patent
applications filed or in-licensed by us, or that we will not be involved in interference, opposition or invalidity proceedings before
U.S. or non-U.S. patent offices.

The degree of future protection
for our proprietary rights is uncertain because legal means afford only limited protection and may not adequately protect our rights
or permit us to gain or keep our competitive advantage. For example:

| ● | others may be able to make                                                                                                           
 product candidates or develop a platform similar to, or better than, ours in a way that is not covered by the claims of our licensed 
 or owned patents;                                                                                                                    |

| ● | others may be able to make                                                                                                         
 compounds that are similar to our product candidates but that are not covered by the claims of patents we own or that are licensed 
 to us;                                                                                                                             |

| ● | we or our prospective licensors                                                                                                        
 or future collaborators might not have been the first to make the inventions covered by any pending patent applications issued patents 
 that we own or license;                                                                                                                |

<div align='center'>46</div>

| ● | we or our prospective licensors                                                                                                    
 or future collaborators might not have been (or may not be in the future) the first to file patent applications for certain of our 
 inventions;                                                                                                                        |

| ● | others may independently                                                                                                              
 develop similar or alternative technologies or duplicate any of our technologies without infringing our intellectual property rights; |

| ● | our pending patent applications 
 may not lead to issued patents; |

| ● | issued patents that we                                                                                            
 own or license may be held invalid or unenforceable as a result of legal challenges by our competitors or others; |

| ● | our competitors might conduct                                                                                                       
 R&D activities in countries where we do not have patent rights and then use the information learned from such activities to develop 
 competitive products for sale in our major commercial